Cresols
Medchemexpress LLC M-MLV Reverse transcriptase | 9068-38-6 | 1 KU
M-MLV Reverse transcriptase (M-MLV RT) is an enzyme derived from the Moloney murine leukemia virus. It is primarily used in scientific research and drug registration applications.
- Activity: 200 U/μL.
- Unit defined as the incorporation of 1 nmol of dTTP into an acid-insoluble fraction.
- cDNA products can be stored at -20°C or -80°C, or used immediately for PCR (qPCR) reactions.
BIOHIPPO h/m CD36-sh-BSD
h/m CD36-sh-BSD shRNA lentiviral vector expressing with Blasticidin selection for studies in Human/Mouse Each vial provides a nominal titer of 5x10E6 transducing units TU Validated h/m CD36 shRNA Lentivirus High-titer shRNA lentiviral particles specific for human/mouse CD36 molecule (CD36) The shRNA has been validated to meet or exceed 70% CD36 knockdown efficiency using a specific fluorescence-based method that is more rapid and reliable than qPCR The shRNA lentivirus is ultra-purified and concentrated to high-titer by PEG precipitation and sucrose gradient centrifugation and ideal for transducing difficult-to-transfect cells including thawed and/or primary cells Order a shRNA lentivirus set and receive lentivirus produced from mix of 2 independent shRNAs validated to knockdown the target gene ( 70%) plus control lentivirus produced from mix of 2 scrambled shRNA constructs
Medchemexpress LLC m-Tolylacetic acid | 621-36-3 | MFCD00004340 | 99.9% | 150.18 | C9H10O2 | 1 ML
m-Tolylacetic acid (3-methylbenzeneacetic acid) is an organic compound used as a chemical intermediate and analytical standard. Supplied as a 10 mM solution (1 mL) in DMSO, it is intended for research and analytical applications where high purity reagents are required.
- Used as a chemical intermediate and analytical standard.
- Available as a 10 mM solution in 1 mL DMSO suitable for assay preparation.
- High purity suitable for analytical use (HPLC purity 99.93%).
- Store powder and solutions at recommended temperatures to preserve stability.
Apexbio Technology LLC EZ Cap Mouse RLI mRNA (m1Ψ) 1mg (1mg/mL)
Mouse RLI mRNA encodes a fusion protein composed of interleukin-15 (IL-15) fused to the sushi domain of its receptor IL-15R representing an innovative immunotherapeutic agent As a crucial cytokine IL-15 stimulates proliferation of natural killer (NK) cells and T cells thus enhancing immune responses against tumor cells and viruses The IL-15/IL-15R -sushi fusion protein shows promise in cancer immunotherapy by enhancing immune cell function and promoting clearance of tumor cells EZ Cap Mouse RLI mRNA (m1 )is supplied at 1 mg/mL expresses mouse-derived RLI fusion protein It contains a cap 1 structure generated through co-transcriptional capping Incorporation of modified nucleotides m1 along with a poly (A) tail minimizes RNA-induced innate immune activation and enhances mRNA stability and lifespan both in vitro and in vivo